Staff Profile
Dr Ashleigh Kernohan
Senior Research Associate
- Telephone: 0191 208 8487
- Address: Population Health Sciences Institute
Newcastle University
Baddiley-Clark Building
Richardson Road
Newcastle upon Tyne
NE2 4AX
Ashleigh Kernohan is a Senior Research Associate based in the Population Health Science Institute at Newcastle University. She qualified as a community optometrist and practiced in several different clinical contexts before completing a PhD in health economics and taking up a post as a health economist.
She has been a co-applicant on a number of NIHR funded projects with the role of evaluating the costs and benefits of different interventions with a special interest in eye disease. She has also recently completed a project as a co-primary investigator evaluating different surgical approaches to retinal detachment (the EYE CHOOSE project). Her research interests include different evaluation methods in the context of eye care, understanding the role of community practitioners in eye care, and valuation methods to better understand the preferences of the general public and patients with regard to eye disease.
Areas of expertise
- Economic Evaluation
- Systematic Review
- Preference Elicitation
Qualifications
- PhD – “An Economic Evaluation of community eye disease” – Glasgow Caledonian University
- BSc Hons – Optometry (1st class) – Glasgow Caledonian University - 2011
Google scholar: Click here.
-
Articles
- Robinson T, Hill S, Orozco-Leal G, Kernohan A, King W, Oluboyede Y. Valuing selected WAItE health states using the Time Trade-Off methodology: findings from an online interviewer-assisted remote survey. Journal of Patient-Reported Outcomes 2024, 8(1).
- Niestrata M, Deeks JJ, Takwoingi Y, Sivaprasad S, Patel PJ, Keane PA, Kernohan A, Vale L, Denniston AK, Gale R, Khan AR, McKinnon W, Agarwal R, de Salvo G, Minos E, Barbeiro P, Chakravarthy U, Waheed NK, Madhusudhan S, Peto T, Balaskas K. Study protocol: optical coherence tomography angiography for the detection of neovascular age-related macular degeneration: a comprehensive multicentre diagnostic accuracy study in the UK-the ATHENA study. BMJ Open 2024, 14(5), e070857.
- Taithongchai A, Johnson EE, Ismail SI, Wallace SA, Thakar R. Oestrogen therapy for preventing pelvic organ prolapse in postmenopausal women. Cochrane Database of Systematic Reviews 2024, 2024(2), CD015695.
- Coughlan D, Arisa O, Thomson K, Yu G, Pearson F, Kernohan A, Garcia Gonzalez-Moral S, Wallace S, Rice S. Disease Severity Modifier in the NICE Single Technology Appraisal of Trastuzumab Deruxtecan: External Assessment Group Perspective. PharmacoEconomics 2024, 42, 5-9.
- Kernohan A, Homer T, Shabaninejad H, King AJ, Hudson J, Fernie G. Cost-effectiveness of primary surgical versus primary medical management in the treatment of patients presenting with advanced glaucoma. British Journal of Ophthalmology 2023, 107(10), 1452-1457.
- Rodgers J, Goodwin J, Garland D, Grahame V, Isard L, Kernohan A, Labus M, Osborne M, Parr JR, Rob P, Wright C, Freeston M. Coping with uncertainty in everyday situations (CUES©) to address intolerance of uncertainty in autistic children: an intervention feasibility trial. Journal of Autism and Developmental Disorders 2023, 53, 3460-3474.
- Orozco leal G, Armstrong N, Kernohan A, Ahmadu C, Coughlan D, McDermott K, Duffy S, O'Meara S, Robinson T, Vale L, Kleijnen J. Abemaciclib in Combination with Endocrine Therapy for Adjuvant Treatment of Hormone Receptor-Positive, HER2-Negative, Node-Positive Early Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics 2023, 41(7), 741-750.
- Suklan J, Cheaveau J, Hill S, Urwin SG, Green K, Winter A, Hicks T, Boath AE, Kernohan A, Price DA, Allen AJ, Moloney E, Graziadio S. Utility of Routine Laboratory Biomarkers to Detect COVID-19: A Systematic Review and Meta-Analysis. Viruses 2021, 13(5), 803.
- Taithongchai A, Ismail SI, Johnson E, Barron Millar E, Kernohan A, Thakar R. Oestrogen therapy for treating pelvic organ prolapse in postmenopausal women (Protocol). Cochrane Database of Systematic Reviews 2021, (5), CD014592.
- Learoyd AE, Tufail A, Bunce C, Keane PA, Kernohan A, Robinson E, Jaber A, Sadiq S, Harper R, Lawrenson J, Vale L, Waterman H, Douiri A, Balaskas K, FENETRE study group. FENETRE study: Quality-assured follow-up of quiescent neovascular age-related macular degeneration by non-medical practitioners: Study protocol and statistical analysis plan for a randomised controlled trial. BMJ Open 2021, 11(5), 049411.
- Goodwin J, Rob P, Freeston M, Garland D, Grahame V, Kernohan A, Labus M, Osborne M, Parr J, Wright C, Rodgers J. Caregiver perspectives on the impact of uncertainty on the everyday lives of autistic children and their families. Autism 2021, 26(4), 827-838.
- Grahame V, Dixon L, Fletcher-Watson S, Garland D, Glod M, Goodwin J, Grayson Z, Heron S, Honey E, Iversen R, Kasim AS, Kernohan A, Kharatikoopaei E, Le Couteur A, Mackie L, Mathias A, Probert H, Riby D, Rob P, Rogan L, Thompson S, Vale L, Walls E, Webb EI, Weetman C, Wolstenhulme F, Wood R, Rodgers J. A clinical and cost-effectiveness trial of a parent group intervention to manage challenging restricted and repetitive behaviours in young children with autism spectrum disorder: study protocol for a randomised controlled trial. Trials 2021, 22(1), 240.
- Hanna C, Lawrie T, Rogozinska E, Kernohan A, Jefferies S, Bulbeck H, Ali U, Robinson T, Grant R. Treatment of newly diagnosed glioblastoma in the elderly: a network meta‐analysis. Cochrane Database of Systematic Reviews 2020, (3).
- Bhattarai N, Mason H, Kernohan A, Poole M, Bamford C, Robinson L, Vale L. The value of dementia care towards the end of life: A contingent valuation study. International Journal of Geriatric Psychiatry 2020, 35(5), 489-497.
- Grant R, Dowswell T, Tomlinson E, Brennan PM, Walter FM, Ben-Shlomo Y, Hunt DW, Bulbeck H, Kernohan A, Robinson T, Lawrie TA. Interventions to reduce the time to diagnosis of brain tumours. Cochrane Database of Systematic Reviews 2020, (9), CD013564.
- Rodgers J, Goodwin J, Parr JP, Grahame V, Wright C, Padget J, Garland D, Osborne M, Labus M, Kernohan A, Freeston M. Coping with Uncertainty in Everyday Situations (CUES©) to address Intolerance of Uncertainty in autistic children: Study protocol for an intervention feasibility trial. Trials 2019, 20, 385.
-
Report
- Robinson L, Poole M, McLellan E, Lee R, Amador S, Bhattarai N, Bryant A, Coe D, Corbett A, Exley C, Goodman C, Gotts Z, Harrison-Dening K, Hill S, Howel D, Hrisos S, Hughes J, Kernohan A, Macdonald A, Mason H, Massey C, Neves S, Paes P, Rennie K, Rice S, Robinson T, Sampson E, Tucker S, Tzelis D, Vale L, Bamford C. Supporting good quality, community-based end-of-life care for people living with dementia: the SEED research programme including feasibility RCT. National Institute for Health Research, 2020. 8.
-
Reviews
- Hargreaves E, Baker K, Barry G, Harding C, Zhang Y, Kandala N-B, Zhang X, Kernohan A, Clarkson CE. Acupuncture for treating overactive bladder in adults. The Cochrane database of systematic reviews 2022, 9, CD013519.
- McAleenan A, Kelly C, Spiga F, Kernohan A, Cheng H-Y, Dawson S, Schmidt L, Robinson T, Brandner S, Faulkner CL, Wragg C, Jefferies S, Howell A, Vale L, Higgins JPT, Kurian KM. Prognostic value of test(s) for O6-methylguanine–DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide. Cochrane Database of Systematic Reviews 2021, 2021(3), : CD013316.
- Woodley SJ, Lawrenson P, Boyle R, Cody JD, Morkved S, Kernohan A, Hay-Smith EJC. Pelvic floor muscle training for preventing and treating urinary and faecal incontinence in antenatal and postnatal women. Cochrane Database of Systematic Reviews 2020, 5, CD007471.